meddevicedb.com FDA Device Reference

cobas liat Bordetella panel nucleic acid test

K243753 Class II Dual Track
Decision Date
2025-11-20
Sponsor / Applicant
Roche Molecular Systems, Inc.

Technical Specification

510(k) Submission ID K243753
Product Code OZZ
Medical Specialty / Panel Microbiology
Regulation Citation 21 CFR 866.3980
Decision Date 2025-11-20
Clearance Pathway Dual Track

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

cobas liat Bordetella panel nucleic acid test received FDA 510(k) clearance under submission number K243753, sponsored by Roche Molecular Systems, Inc.. The device was reviewed via the Dual Track premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2025-11-20.

Classification & Regulation

This clearance is catalogued under FDA product code OZZ and 21 CFR 866.3980, within the Microbiology review panel as a Class II device.